After having taken Tarceva for one year with some success I might now have to move to the next treatment down the line since progression ( lung , brain ) is getting more pronounced.
I do have a relatively unrelated question though.
My latest Ct scan showed a new minimal pancreatic ductal dilatation in the body and neck measuring 3mm.
No pancreatic mass identified .
The radiologist added that this is of questionable significance.
Does his statement mean that the lung cancer will have killed me long before the pancreas will become an issue?
I did read that ductal dilatation means high risk for developing pancreatic cancer down the line, and assume this would be a new primary?
Although as you say this finding may indicate a higher risk of developing pancreatic cancer, usually a radiologist’s comments relate more to interpretation of what the scan shows, rather than the kind of “big picture” observation you suggest.
To get an idea of what the finding may represent, a conversation with your oncologist would be in order.
Jul 2008 Wife Liz (51/never smoker) Dx Stage IV NSCLC EGFR exon 19
4 cycles Carbo/alimta, 65% shrinkage
Mar 2010 progression, added Alimta, stable
Sep 2010 multiple brain mets, WBR
Oct 2010 large pericardial effusion, tamponade
Jan 2011 progression, start abraxane
Jun 2011-New liver, brain mets, add Tarceva
Oct 2011-Dx Leptomeningeal carcinomatosis; pulsed Tarceva
At rest Nov 4 2011
Since then: http://cancergrace.org/blog/jim-and-lisa